Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 6 Month, Double-blind Safety Extension Study of MBGS205

NCT02908074 is registered in ClinicalTrials.gov with Mereo BioPharma as lead sponsor.

NCT NCT02908074
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02908074 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 6 Month, Double-blind Safety Extension Study of MBGS205
Lead sponsor
Mereo BioPharma
Phase
Phase 2
Overall status
Completed
Start date
November 15, 2016
Completion date
November 21, 2018
Enrollment
143 (actual)
Sites
37

Conditions

As the registry lists them; a condition with its own page is linked.

hypogonadotropic hypogonadism